Functional Splint for Osteoarthritis of the Trapeziometacarpal Joint
NCT ID: NCT00612248
Last Updated: 2008-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
40 participants
INTERVENTIONAL
2005-07-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Trapeziometacarpal Splint
NCT02635932
Collagen-based Filler for Trapeziometacarpal Osteoarthritis
NCT06881186
The Effects of Two Different Orthosis on Pain, Hand Strength and Function in Patients With Thumb Carpometacarpal Osteoarthritis
NCT03327480
Trapeziectomy vs. Trapeziometacarpal Limited Excision for Thumb Base Osteoarthritis
NCT04210687
Trapeziectomy and Suture Suspensionplasty for Thumb Carpometacarpal Arthritis - Is In-Clinic Therapy Needed?
NCT06820528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SG
Study group
Splint
Patients in the study group received the splint on the day of the first evaluation and took it with them for use during activities of daily living and patients in the control group only used the splint during the evaluations
CG
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Splint
Patients in the study group received the splint on the day of the first evaluation and took it with them for use during activities of daily living and patients in the control group only used the splint during the evaluations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* either gender;
* over 40 years of age;
* pain in the base of the thumb of the dominant hand greater than three and less than or equal to seven on the 0 to 10-cm visual analogue scale (VAS) for pain.
Exclusion Criteria
* deformities of distal interphalangeal joint;
* use of a splint on the thumb in the previous six months;
* surgery on the hand under study in the previous six months or scheduled in the upcoming six months;
* allergy to the splint material;
* incapacity to respond to the questionnaire and perform the tests;
* geographic inaccessibility;
* injections in the hand under study in the previous six months;
* other associated diseases such as carpal tunnel syndrome, fractures in the carpus, tendonitis, chronic inflammatory arthropathy;
* alterations in the use of anti-inflammatory medication and analgesics in the previous three months.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UNIFESP - Universidade Federal de Sao Paulo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamil Natour, MD
Role: STUDY_CHAIR
Federal University of São Paulo
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEP1090/03
Identifier Type: -
Identifier Source: secondary_id
UNIFESP0108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.